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ABSTRACT
CONTEXT AND OBJECTIVE: Systemic sclerosis is an autoimmune disease characterized by abnormalities 
of vascularization that may cause fibrosis of the skin and other organs and lead to dysfunction. It is there-
fore essential to have tools capable of evaluating function in individuals with this condition. The aim of this 
study was to translate the Scleroderma Health Assessment Questionnaire (SHAQ) into Portuguese, adapt 
it to Brazilian culture and test its validity and reliability. 
DESIGN AND SETTING: The validation of SHAQ followed internationally accepted methodology, and was 
performed in university outpatient clinics. 
METHODS: SHAQ was translated into Portuguese and back-translated. In the cultural adaptation phase, 
it was applied to 20 outpatients. Items not understood by 20% of the patients were modified and applied 
to another 20 outpatients. Twenty patients were interviewed on two different occasions to determine the 
validity and reliability of the questionnaire: two interviewers on the first occasion and one interviewer 14 
days later. To determine the external validity, comparisons were made with Health Assessment Question-
naire (HAQ), Disabilities of the Arm, Shoulder and Hand (DASH) and short form-36 (SF-36). 
RESULTS: In the interobserver evaluation, Pearson’s correlation coefficient and the intraclass correlation 
coefficient were both 0.967. In the intraobserver evaluation, Pearson’s correlation coefficient was 0.735 and 
the intraclass correlation coefficient was 0.687. Regarding external validity, SHAQ scores were statistically 
correlated with all measurements, except the general health domain of SF-36 and the work-related score 
(Q2) of DASH.
CONCLUSION: The Brazilian version of SHAQ proved to be valid and reliable for assessing function in 
patients with diffuse systemic sclerosis. 
RESUMO
CONTEXTO E OBJETIVO: A esclerose sistêmica (ES) é uma doença autoimune caracterizada por anorma-
lidades da vascularização, que podem gerar fibrose da pele e outros órgãos, podendo levar a disfunção. 
Assim, torna-se imprescindível a elaboração de instrumentos capazes de avaliar a função de indivíduos 
com ES. O objetivo deste estudo foi traduzir para o português, adaptar à cultura brasileira e testar a valida-
de e confiabilidade do Scleroderma Health Assessment Questionnaire (SHAQ). 
TIPO DE ESTUDO E LOCAL: A validação do SHAQ seguiu uma metodologia aceita internacionalmente, e 
foi realizada nos ambulatórios da universidade. 
MÉTODOS: Foi realizada tradução e contra-tradução do instrumento. Na fase de adaptação cultural, o 
SHAQ foi aplicado a 20 pacientes. As questões que apresentaram mais de 20% de incompreensão foram 
modificadas e aplicadas em outros 20 pacientes. Para validade e confiabilidade, 20 pacientes foram en-
trevistados em dois momentos: no primeiro, por dois entrevistadores e após 14 dias por um deles. Foram 
aplicados o Health Assessment Questionnaire (HAQ), o Disabilities of the Arm, Shoulder and Hand (DASH) 
e o short form-36 (SF-36), para a validade externa. 
RESULTADOS: Na avaliação interobservador, o coeficiente de correlação de Pearson e o coeficiente de 
correlação intraclasse foram ambos de 0,967. Na avaliação intraobservador o coeficiente de correlação de 
Pearson foi de 0,735, e o coeficiente de correlação intraclasse foi de 0,687. Na validade externa, os escores 
do SHAQ foram associados estatisticamente com todos os instrumentos, exceto com o domínio estado 
geral de saúde do SF-36 e o escore relacionado ao trabalho (Q2) do DASH. 
CONCLUSÃO: A versão brasileira do SHAQ mostrou ser válida e confiável para a avaliação de função em 
pacientes com esclerose sistêmica difusa.
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INTRODUCTION
Systemic sclerosis is an autoimmune disease of connective tissue 
characterized by abnormalities in the vascular system, immune 
system and extracellular matrix. It can lead to fibrosis of the skin 
and other organs, such as the lungs, gastrointestinal tract, heart 
and kidneys.1 Systemic scleroderma is a heterogeneous disease 
ranging from a mild form characterized by lesser involvement 
of internal organs to a more severe type characterized by greater 
involvement of these organs and rapid progression, leading to 
disability and even death in some cases.2 
Systemic sclerosis affects women more than men, in propor-
tions of 4:1.3 The prevalence ranges from seven to 489 cases per 
million individuals. This variation has been correlated to age, 
region and gender.4 The incidence is greatest among middle-aged 
women and the main characteristics are Raynaud’s phenomenon, 
thickening of the skin and dysfunction in internal organs.5
This disease leads to dysfunction and a reduction in life 
expectancy. Treatment should involve improving quality of life. It 
is therefore essential to have reliable assessment tools for evaluat-
ing function in individuals with systemic scleroderma. However, 
there are currently no specific tools validated in Brazilian 
Portuguese for evaluating function in such individuals.
The Health Assessment Questionnaire (HAQ)6 has been val-
idated for the Brazilian Portuguese language7 and assesses func-
tional capacity through 20 questions distributed among eight 
domains, addressing activities performed with the upper and lower 
limbs. The final score ranges from 0 to 3 points, such that higher 
scores denote worse functional capacity. This questionnaire has 
been widely used for evaluating function in individuals with dif-
ferent musculoskeletal diseases, especially rheumatoid arthritis.8
The Scleroderma Health Assessment Questionnaire (SHAQ) 
is one of the few measurement tools for evaluating function in 
individuals with systemic scleroderma and has been used in  a 
number of countries.8-10 Like HAQ, SHAQ is made up of 20 
items distributed among eight domains and has five additional 
domains that assess dysfunctions caused by the symptoms of sys-
temic scleroderma. For this, five visual analogue scales (VASs) 
are used. The scores on these scales are converted to subscores 
ranging from 0 to 3 points. The overall score of the questionnaire 
is the sum of each of the five VAS subscores and the scores for the 
eight domains, divided by 13.8 
OBJECTIVE
The aim of the present study was to translate the Scleroderma 
Health Assessment Questionnaire into Brazilian Portuguese, 
adapt it to Brazilian culture and test its validity and reliability.
METHODS
This study was carried out in two stages. The first stage con-
sisted of translation of SHAQ into Brazilian Portuguese and 
cross-cultural adaptation to the Brazilian population. The second 
stage consisted of determining the reliability and external valid-
ity of the Brazilian version of SHAQ. This study was approved by 
our institution’s Research Ethics Committee.
Translation and cross-cultural adaptation 
The translation, validation and adaptation of the questionnaire were 
carried out following the method proposed by Guillemin et al.11,12
Translation to the Portuguese language
SHAQ was translated independently by two teachers of English 
who were informed about the aim of the study. The two versions 
of the questionnaire in Portuguese were analyzed and compared 
by a team made up of two rheumatologists and three physiother-
apists, who examined the questionnaire for possible translation 
problems and analyzed the applicability of each item. This pro-
cess generated a single translated version of SHAQ (V1).
Assessment of initial translation (back translation)
V1 was then back-translated into English by two English-
language teachers who were fluent in Portuguese. In this 
phase, the teachers were unaware of the original questionnaire 
or the aim of the study. The two back-translated versions were 
compared with the original questionnaire by the same team, 
in order to determine the semantic and grammatical equiv-
alence, ensuring the similarity between the original ques-
tionnaire and V1, which could be used as the final version of 
the questionnaire (Annex).
Sample
A total of 60 male and female patients between 18 and 65 years of 
age with systemic scleroderma were recruited from our institu-
tion’s outpatient clinics. For patients to be included, they needed 
to fulfill the clinical criteria for the diagnosis of systemic sclero-
sis.13 Authorization was obtained from the authors of SHAQ for 
its use in the present study. 
Assessment of comprehension (cultural equivalence)
The final Portuguese version (V1) of SHAQ was applied to 20 
patients with systemic scleroderma in order to assess the degree of 
comprehension of each item. All items that were considered incom-
prehensible or not applicable by at least 20% of the patients were 
revised and modified, and were then applied to 20 different patients.
Assessment of measurement properties 
Reliability 
Following the translation and cross-cultural adaptation of SHAQ, 
it was applied to a new group of 20 patients with systemic sclero-
derma. Two evaluations were performed consecutively on the 
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same day by two researchers in order to determine the interob-
server agreement. A third evaluation was carried out by one of 
the initial researchers after an interval of 7 to 14 days in order 
to determine the intraobserver agreement. A questionnaire 
addressing sociodemographic issues was also applied at this stage 
in order to characterize the sample.
External validity
The external validity of SHAQ was tested through correlations 
with other clinical parameters: quality of life, using the short 
form-36 (SF-36) questionnaire;14 upper limb function using 
the Disabilities of the Arm, Shoulder and Hand (DASH) ques-
tionnaire;15 and overall function, using the HAQ,7 in the sec-
ond evaluation.
Statistical analysis
Descriptive statistics (means and standard deviations) were 
used to analyze the clinical-demographic data on the patients. 
Pearson’s correlation coefficient and the intraclass correlation 
coefficient (ICC) were calculated in order to evaluate the interob-
server and intraobserver agreement. Pearson’s correlation coef-
ficient was also used, in order to determine the external validity.
RESULTS
In the cross-cultural adaptation, two items were not understood 
by more than 20% of the patients and were changed. In the first 
item, the patients had difficulty regarding the term “Raynaud’s 
phenomenon” and the following was added to explain the mean-
ing of this term: “fingers that alternate in color between purple, 
paleness and red, due to the cold”. In the second item, “digital 
ulcers” was replaced by “sores on the fingers”. Only these two 
modified itens were then applied to a new group of 20 patients 
with systemic scleroderma and were understood by more than 
80% of the sample.
Assessment of measurement properties
Characterization of the sample
Table 1 displays the clinical and demographic characteristics of 
the 20 patients who participated in determining the reliability 
and validity of SHAQ. All of these 20 patients had a diagnosis of 
diffuse systemic scleroderma. The mean duration of symptoms 
was 10.7 years (range: 2 to 36 years) and the mean time that had 
elapsed since diagnosis was 7.1 years (range: 1 to 19 years).
Reliability 
In the interobserver evaluation, Pearson’s correlation coefficient 
and the intraclass correlation coefficient were both 0.967 and 
were considered statistically significant (P < 0.001). The paired 
Student’s t test did not show any statistically significant differ-
ences in the findings between the two observers (P = 0.320).
In the intraobserver evaluation, Pearson’s correlation coef-
ficient was 0.735 and the intraclass correlation coefficient was 
0.687. These results were also considered statistically significant 
(P < 0.001). The paired Student’s t test did not show any statisti-
cally significant differences in the findings between the two dif-
ferent evaluations (P = 0.055) (Table 2).
External validity 
To determine the external validity, SF-36,14 DASH15 and HAQ7 
were administered to 20 patients. SHAQ scores were statistically 
associated (P < 0.05) with all measurements, except the general 
health domain of SF-36 and the work-related score (Q2) of the 
DASH questionnaire (Table 3).
DISCUSSION
Two options are available for obtaining new health assessment 
measurements: developing a new assessment tool that addresses 
the issue in question; or translating an existing questionnaire 
that has demonstrated adequate applicability in other countries. 
The former is considered to be time-consuming and labor-inten-
sive. Thus, translation of good-quality questionnaires is pref-
erable, since the evaluation should be universal, thus enabling 
Table 1. Clinical and demographic characteristics of the 20 patients 
who participated in determining the reliability and validity of the 
Scleroderma Health Assessment Questionnaire
Clinical-demographic data
Gender – F/M 18/02
Race (n %)
White 11 (55)
Nonwhite 9 (45)
Age - mean (SD) 43.7 (11.7)
Marital status (n %)
Married 10 (50)
Single 5 (25)
Others 5(25)
Education level - n (%)
Incomplete elementary education 9 (45)
Completed elementary education 4 (20)
Others 6(35)
Duration of symptoms, years - mean (SD) 10.7 (8.9)
Time since diagnosis, years - mean (SD) 7.1 (4.5)
F = female; M = male; SD = standard deviation.
Table 2. Interobserver and intraobserver reliability 
Reliability
Interobserver Intraobserver
PCC (P value) 0.967 (< 0.001) 0.735 (< 0.001)
ICC (P value) 0.967 (< 0.001) 0.687 (< 0.001)
PCC = Pearson’s correlation coefficient; ICC = intraclass correlation coefficient.
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comparison of data from one population with data from other 
populations throughout the world.15
A number of questionnaires in Portuguese have been admin-
istered to patients with chronic diseases, in order to assess func-
tion,7,15,16 but none of them are specific to the symptoms of 
systemic scleroderma. Since SHAQ is a valid, reliable question-
naire17,18 and has been used in a number of countries,9,10 this ques-
tionnaire was chosen for translation into Brazilian Portuguese in 
the present study.
An internationally accepted method that was specially cre-
ated to systematize translation of questionnaires was used in this 
study.11,12 This is the only way to ensure that the translation pres-
ents an equivalent context, in comparison with the original ques-
tionnaire. However, translation alone is insufficient for ensuring 
that a given questionnaire is reliable. It is also necessary to per-
form cross-cultural adaptation of the text, which may undergo 
modifications while respecting the initially proposed context and 
ideas.11 In the present study, the entire translation and cross-cul-
tural adaptation process was carried out at our institution’ outpa-
tient clinics. Most of the patients in these clinics had lower socio-
economic and schooling levels, thereby representing an important 
portion of the Brazilian population that receives medical care in 
this and other reference centers throughout the country.
Given the low schooling level of the patients in the present 
study, SHAQ was applied in interview form, which was done in 
order to increase the number of people on whom the question-
naire could be used. This method has also been used in previous 
studies.7,14,15 In the study by Steen et al.,9 who created SHAQ, and 
Georges et al.,10 who validated the French version, the question-
naires were self-administered.
HAQ has been used to assess overall physical function and 
has items addressing different activities of daily living, such as 
eating, having a bath and walking. Poole and Steen19 adminis-
tered HAQ to patients with systemic scleroderma and concluded 
that this measurement was inadequate for assessing all the symp-
toms and manifestations of the disease. Thus, Steen and Medsger 
added five visual analogue scales (VASs) to HAQ, thereby creat-
ing SHAQ,9 which was validated in France in 2003.10 The addition 
of these five VASs addressing the symptoms of systemic sclero-
derma makes SHAQ a specific questionnaire that assesses func-
tion in patients with this disease.18 The VAS relating to Raynaud’s 
phenomenon was not validated in the original questionnaire, but 
was administered in the study by Georges et al.10 in order to vali-
date the French version of SHAQ.
Both HAQ and SHAQ have been applied together in order 
to compare data and determine the validity of the five VASs that 
were added to the former.18 This author reported that both ques-
tionnaires were sensitive for assessing difficulties in performing 
activities of daily living, among patients with systemic sclero-
derma, and that SHAQ enhances HAQ, since it assesses the 
impact of the symptoms of the disease on daily activities. 
Following translation, the Brazilian version of SHAQ was 
found to contain technical terms that were not widely known 
by the general population and were therefore difficult to 
understand. Thus, the terms Raynaud’s phenomenon and digi-
tal ulcers were changed without altering the meaning of the 
items. In contrast, no changes had to be made to the French 
version of the SHAQ.10 
In characterizing the sample, the mean age of the 20 par-
ticipants was 43.7 years; 90% were women and 10% were men. 
In the study by Georges et al.,10 the mean age was 50 years; 76% 
of the participants were women and 24% were men. The female 
gender predominates because this disease affects women more.3
A high level of agreement was found in assessing interob-
server reliability, whereas a moderate level of agreement was 
found in assessing intraobserver reliability. This finding may 
be attributed to the fact that intraobserver reliability was deter-
mined with a 14-day interval between evaluations. Some symp-
toms of systemic scleroderma are dependent on the weather, such 
as Raynaud’s phenomenon and lung problems. Changes in the 
weather within a two-week timeframe are enough to change the 
symptoms of the disease, which could change the VAS scores, 
thereby affecting the reproducibility of SHAQ. However, in the 
study by Georges et al.,10 the interval between the assessments 
for determining intraobserver reliability ranged from one week 
to one month, and the authors reported a test-retest coefficient 
of 0.98, even with the large time interval between evaluations. 
Despite this difference, the Brazilian version of SHAQ proved to 
be reproducible.
Table 3. Pearson’s correlation between Scleroderma Health 
Assessment Questionnaire (SHAQ) and short form-36 (SF-36), Health 
Assessment Questionnaire (HAQ) and Disabilities of the Arm, Shoulder 
and Hand (DASH)
Questionnaires Score - mean (SD) Correlation with SHAQ
SHAQ 0.910 (0.681)
Pearson’s 
correlation
P-value
SF-36
Physical function 63.8 (28.1) -0.843 < 0.001
Role - physical problems 47.5 (45.1) -0.684 0.001
Body pain 68.2 (30.5) -0.839 < 0.001
General health 59.1 (20.1) -0.436 0.054
Vitality 52 (50)
Social function 83.1 (27) -0.646 0.002
Role - emotional problems 63.3 (45.8) -0.565 0.009
Mental health 63.8 (29.5) -0.656 0.002
DASH
Component 2: work 17.9 (25.9) 0.546 0.128
Component 3: overall score 25.9 (21.5) 0.948 < 0.001
HAQ 0.844 (0.749) 0.96 < 0.001
Values expressed as mean (standard deviation, SD).
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Quality of life was assessed using the SF-36 questionnaire. 
The scores on the functional capacity, role-physical, pain, 
role-emotional, vitality, social aspects and mental health sub-
scales demonstrated strong correlations with the SHAQ score. 
The  only non-significant correlation was with the general 
health state subscale. Correlations between these two measure-
ments were expected, since physical impairment is often asso-
ciated  with reductions in both physical and mental health in 
patients with systemic scleroderma.20 Moreover, a systematic 
review has reported that symptoms of depression are found 
in 36 to 65% of such patients and are strongly associated with 
joint pain as well as the duration and severity of the disease.21 
In the study by Georges et al.,10 all the SF-36 subscales were sta-
tistically correlated with the SHAQ score. With chronic disease, 
inactivity stemming from pain leads to a greater risk of acceler-
ated loss of muscle mass, with consequent reduction in muscle 
strength and diminished level of independence, thereby con-
tributing towards a reduction in quality of life.22
HAQ was also statistically correlated with SHAQ, and the 
P-value demonstrated that the scores were directly proportional. 
This finding was expected, since SHAQ is the same as HAQ with 
the addition of the five VASs. The mean score for the questionnaire 
was 0.844. In a study by Singh et al.,23 which assessed productiv-
ity among patients with systemic scleroderma, HAQ for patients 
with the diffuse form of the disease was 1.2 (SD = 0.7). It needs to 
be borne in mind that higher scores are associated with a lower 
degree of productivity.23 Georges et al.10 found a very strong cor-
relation between the two questionnaires, as well as strong correla-
tions between these questionnaires and the severity of the disease. 
The DASH questionnaire is commonly used to assess upper-
limb conditions and was used in the present study because thick-
ening of hand skin is one of the most common symptoms of sys-
temic scleroderma and the reason for loss of hand function. This 
questionnaire proved to be correlated with SHAQ. In the present 
study, the score for component 1 was not calculated, since this 
component was only relevant to two patients, which rendered 
statistical description impossible. 
Higher SHAQ scores were found in the present study than 
in the study by Georges et al.,10 who reported a mean score of 
0.02. In the present study, all the patients had diffuse systemic 
scleroderma, which affects internal organs and commonly 
presents symptoms of greater severity than is seen in cases of 
limited scleroderma, thereby increasing these patients’ dys-
function and consequently leading to higher scores in ques-
tionnaires that assess this variable. In the study by Georges 
et al.,10 77% of the patients had diffuse systemic scleroderma 
and the remaining patients were classified as presenting the 
limited form of the disease, which may explain the difference 
in scores between the two studies. 
Disease duration was similar in the two studies. In the pres-
ent study, the mean duration of symptoms was 10.7 years, which 
may explain the low scores found in evaluating upper limb func-
tion using DASH, since patients tend to develop adaptations to 
maintain their activities of daily living. This may also explain the 
low score on the “role-physical” subscale of the SF-36 question-
naire. The majority of the patients reported typical symptoms 
of systemic scleroderma throughout the present study, such as 
Raynaud’s phenomenon, respiratory and digestive problems, 
digital ulcers and thickening of the skin, which affect the SHAQ 
score. In the study by Georges et al.,10 68% of the patients had 
Raynaud’s phenomenon in the final week; approximately 50% 
had respiratory, digestive and heart problems and only 25% expe-
rienced contractures in the hands. These findings may explain 
the differences in SHAQ scores between the two studies.
Although the original questionnaire was tested for both 
forms of progressive systemic scleroderma, the Brazilian version 
was produced only using patients with diffuse systemic sclero-
derma. The Brazilian version probably maintains the original 
measured performance, but it needs to be tested on cases of lim-
ited scleroderma.
Previous studies have used other questionnaires that assess 
function, but these questionnaires are not specific to systemic 
scleroderma. Thus, validation of SHAQ enables a more specific 
evaluation of function, directed towards patients with this dis-
ease, thereby making this questionnaire an additional assess-
ment tool of considerable value. The successful translation and 
cross-cultural adaptation of SHAQ will allow future studies to 
assess function in patients with systemic scleroderma and test 
the responsiveness of the questionnaire. Moreover, the use of this 
measurement in different populations allows comparisons of the 
findings across cultures.
CONCLUSION
In conclusion, the Brazilian version of the Scleroderma Health 
Assessment Questionnaire proved to be a valid, reliable measure-
ment tool for assessing function in patients with diffuse systemic 
scleroderma.
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ESCALA VISUAL ANALÓGICA
Faça uma marca na linha abaixo (10 cm) referente ao grau de limitação apresentada pelo indivíduo.
1. Na semana passada, quanto os seus problemas com o Fenômeno de Raynaud (dedos que alternam de cor entre roxo, pálido e 
vermelho pelo frio) interferiram nas suas atividades? Faça uma marca na linha para indicar a gravidade desse problema.
Limitações 
muito gravesNão interfere
2. Na semana passada, quanto os seus problemas com as feridas nos dedos interferiram nas suas atividades? Faça uma marca na linha 
para indicar a gravidade desse problema.
Limitações 
muito gravesNão interfere
3. Na semana passada, quanto os seus problemas gastrointestinais interferiram nas suas atividades? Faça uma marca na linha para indicar 
a gravidade desse problema.
Limitações 
muito gravesNão interfere
4. Na semana passada, quanto os seus problemas com os pulmões interferiram nas suas atividades? Faça uma marca na linha para indicar 
a gravidade desse problema.
Limitações 
muito gravesNão interfere
5. Na semana passada, quanto o conjunto de seus problemas causados pela esclerodermia interferiram nas suas atividades? Faça uma 
marca na linha para indicar a gravidade desse problema.
Limitações 
muito gravesNão interfere
ESCORE
1. Converter cada valor de EVA em subscores de 0-3
2. Somar cada valor do subescore das EVA’s (0-3), com o maior valor de cada um dos 8 domínios
3. Dividir o valor da somatória por 13.
Annex. Scleroderma Health Assessment Questionnaire (SHAQ) questionnaire.
Você é capaz de
(grau de dificuldade)
Sem qualquer Com alguma Com muita
Incapaz de 
fazer
Vestir-se, inclusive amarrar os cordões de sapato e abotoar suas roupas? 0 1 2 3
Lavar sua cabeça e seus cabelos? 0 1 2 3
Levantar-se de maneira ereta de uma cadeira de encosto reto e sem braços? 0 1 2 3
Deitar-se e levantar-se da cama? 0 1 2 3
Cortar um pedaço de carne? 0 1 2 3
Levar à boca um copo ou uma xícara cheia de café, leite ou água? 0 1 2 3
Abrir um saco de leite comum? 0 1 2 3
Caminhar em lugares planos? 0 1 2 3
Subir 5 degraus? 0 1 2 3
Lavar e secar seu corpo após o banho? 0 1 2 3
Tomar banho de chuveiro? 0 1 2 3
Sentar-se e levantar-se do vaso sanitário? 0 1 2 3
Levantar os braços e pegar um objeto de aproximadamente 2 kg, que está 
posicionado um pouco acima da sua cabeça? 
0 1 2 3
Curvar-se para pegar suas roupas no chão? 0 1 2 3
Segurar-se em pé no ônibus ou metrô 0 1 2 3
Abrir potes ou vidros de conservas, que tenham sido previamente abertos? 0 1 2 3
Abrir e fechar torneiras? 0 1 2 3
Fazer compras na redondeza aonde mora? 0 1 2 3
Entrar e sair do ônibus 0 1 2 3
Realizar tarefas tais como usar a vassoura para varrer e rodo para água? 0 1 2 3
Marque com “X” o grau de dificuldade para cada item abaixo.
